This program of projects emphasizes the clinical evaluation of hyperthermia combined with radiotherapy and chemotherapy in treatment of cancer. The program is a collaboration between Duke University Medical Center and the North Carolina State University that utilizes resources of both institutions. Tumor response, duration of response, survival, and normal tissue toxicity are study endpoints in protocols involving humans and canines with spontaneous malignancy. These protocols include, (1) teleradiotherapy with localized hyperthermia in canines with localized extracranial malignancy (Phase II), (2) whole body hyperthermia and cisplatin in canines with extracranial solid tumors (Phase I), and (3) localized and regional hyperthermia combined with radiotherapy or cisplatin in humans (Phase I/II). Study endpoints will be related to temperatures-time distributions that are measured as well be related to temperature-time distributions that are measured as well as modeled through numerical simulation of bioheat transfer. Quantitative, absolute measurements of blood perfusion distributions, essential for the latter simulations, will be measured serially in humans and animals using positron emission tomography. Development of microwave hyperthermia equipment to improve therapy in selected sites of disease is included in an Engineering Core. Core support for biometry and administration is provided. Animal patients are provided through another core, the Animal Core. The overall program goals are to develop a measure of thermal dose that correlates with biological and technical aspects of cancer treatment with hyperthermia, to develop innovative cancer therapy approaches through use of a canine animal model, and to conduct high quality human phase I/II trials involving hyperthermia.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program Projects (P01)
Project #
Application #
Study Section
Clinical Cancer Program Project Review Committee (CCP)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
Schools of Medicine
United States
Zip Code
Stauffer, Paul R; van Rhoon, Gerard C (2016) Overview of bladder heating technology: matching capabilities with clinical requirements. Int J Hyperthermia 32:407-16
Juang, Titania; Stauffer, Paul R; Craciunescu, Oana A et al. (2014) Thermal dosimetry characteristics of deep regional heating of non-muscle invasive bladder cancer. Int J Hyperthermia 30:176-83
Inman, Brant A; Stauffer, Paul R; Craciunescu, Oana A et al. (2014) A pilot clinical trial of intravesical mitomycin-C and external deep pelvic hyperthermia for non-muscle-invasive bladder cancer. Int J Hyperthermia 30:171-5
Angele, Martin K; Albertsmeier, Markus; Prix, Niclas J et al. (2014) Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study. Ann Surg 260:749-54; discussion 754-6
Zagar, Timothy M; Vujaskovic, Zeljko; Formenti, Silvia et al. (2014) Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer. Int J Hyperthermia 30:285-94
Viglianti, Benjamin L; Dewhirst, Mark W; Boruta, R J et al. (2014) Systemic anti-tumour effects of local thermally sensitive liposome therapy. Int J Hyperthermia 30:385-92
Oliveira, Tiago R; Stauffer, Paul R; Lee, Chen-Ting et al. (2013) Magnetic fluid hyperthermia for bladder cancer: a preclinical dosimetry study. Int J Hyperthermia 29:835-44
Dewhirst, Mark W; Landon, Chelsea D; Hofmann, Christina L et al. (2013) Novel approaches to treatment of hepatocellular carcinoma and hepatic metastases using thermal ablation and thermosensitive liposomes. Surg Oncol Clin N Am 22:545-61
Oliveira, Tiago R; Stauffer, Paul R; Lee, Chen-Ting et al. (2013) Preclinical Dosimetry of Magnetic Fluid Hyperthermia for Bladder Cancer. Proc SPIE Int Soc Opt Eng 8584:1656985
van Rhoon, Gerard C; Samaras, Theodoros; Yarmolenko, Pavel S et al. (2013) CEM43°C thermal dose thresholds: a potential guide for magnetic resonance radiofrequency exposure levels? Eur Radiol 23:2215-27

Showing the most recent 10 out of 227 publications